Article in FEBS open bio, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 4 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
9 authors at 1 institution in 1 country.
Nils HampelInstitute of Biochemistry and Molecular Biology II, Medical Faculty, Heinrich Heine University Düsseldorf, Universitätsstrasse 1, Düsseldorf, 40225, Germany.
Jacqueline GeorgyInstitute of Biochemistry and Molecular Biology II, Medical Faculty, Heinrich Heine University Düsseldorf, Universitätsstrasse 1, Düsseldorf, 40225, Germany.
Mehrnaz MehrabipourInstitute of Biochemistry and Molecular Biology II, Medical Faculty, Heinrich Heine University Düsseldorf, Universitätsstrasse 1, Düsseldorf, 40225, Germany.
Alexander LangInstitute of Biochemistry and Molecular Biology II, Medical Faculty, Heinrich Heine University Düsseldorf, Universitätsstrasse 1, Düsseldorf, 40225, Germany.ORCID 0000-0001-6006-7109
Isabell LehmkuhlInstitute of Biochemistry and Molecular Biology II, Medical Faculty, Heinrich Heine University Düsseldorf, Universitätsstrasse 1, Düsseldorf, 40225, Germany.
Jürgen SchellerInstitute of Biochemistry and Molecular Biology II, Medical Faculty, Heinrich Heine University Düsseldorf, Universitätsstrasse 1, Düsseldorf, 40225, Germany.ORCID 0000-0001-9932-1055
Mohammad R AhmadianInstitute of Biochemistry and Molecular Biology II, Medical Faculty, Heinrich Heine University Düsseldorf, Universitätsstrasse 1, Düsseldorf, 40225, Germany.ORCID 0000-0002-2034-8894
Doreen M FlossInstitute of Biochemistry and Molecular Biology II, Medical Faculty, Heinrich Heine University Düsseldorf, Universitätsstrasse 1, Düsseldorf, 40225, Germany.ORCID 0000-0002-6675-5313
Roland P PiekorzInstitute of Biochemistry and Molecular Biology II, Medical Faculty, Heinrich Heine University Düsseldorf, Universitätsstrasse 1, Düsseldorf, 40225, Germany.ORCID 0000-0002-9105-2695
Heinrich Heine University Düsseldorf · DE
Funding
Deutsche Forschungsgemeinschaft AH 92/8-3Foundation for Ageing Research of the Heinrich Heine-University Düsseldorf 701.810.783
6 · The paper itself
Abstract
SIRT4, together with SIRT3 and SIRT5, comprises the mitochondrially localized subgroup of sirtuins. SIRT4 regulates mitochondrial bioenergetics, dynamics (mitochondrial fusion), and quality control (mitophagy) via its NAD
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.